Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

about

New developments in the pathology of malignant lymphoma: a review of the literature published from May to August 2017.CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases.

P2860

Q46210826-BEDDE1CB-7FC5-4011-B9D0-EF065C5E5536 Q51733549-D73F504B-0856-44AF-9135-600EFC26F1DF

P2860

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

Item

http://www.wikidata.org/entity/Q48258021

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

@en

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

@nl

type

Item

label

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

@en

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

@nl

prefLabel

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

@en

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

@nl

P1476

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

@en

P2093

Anna Gazzola

http://www.w3.org/2001/XMLSchema#string

Claudia Mannu

http://www.w3.org/2001/XMLSchema#string

Francesca Galuppini

http://www.w3.org/2001/XMLSchema#string

Gianpietro C Semenzato

http://www.w3.org/2001/XMLSchema#string

Marco Pizzi

http://www.w3.org/2001/XMLSchema#string

Massimo Rugge

http://www.w3.org/2001/XMLSchema#string

Simona Righi

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases.

Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.

BCL6, MUM1, and CD10 expression in mantle cell lymphoma

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells

Nodal marginal zone B-cell lymphoma with prominent follicular colonization - difficulties in diagnosis: a study of 15 cases.

The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

P304

769-777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIS.13286

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28628241

http://www.w3.org/2001/XMLSchema#string

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

about

P2860

P2860

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698